This blend combines BPC-157 (CAS 137525-51-3) and TB-500 (CAS 885340-08-9) in a single vial, two of the most widely studied research peptides among Australian peptide researchers for recovery and tissue-related research. PhaseOne supplies this blend as a high-purity lyophilised powder, independently HPLC verified at ≥98% purity per batch.
Combining both peptides allows researchers across Australia to study their distinct mechanisms - BPC-157's gut and regenerative signalling alongside TB-500's actin regulation and cellular migration research - in a single preparation. (!) Full Certificate of Analysis available for every batch view here.
Researchers across Australia studying recovery and tissue-related pathways often examine BPC-157 and TB-500 together, since each is investigated for a different but complementary mechanism. (!) Read about each individually: BPC-157 and TB-500.
BPC-157 is a regenerative research peptide commonly studied for cellular signalling, gut-related, and tissue-related research pathways within Australian peptide research communities.
TB-500 is studied primarily for actin regulation and cellular migration, derived from the active region of Thymosin Beta-4.
This blend should be stored refrigerated, unreconstituted, and protected from light, in line with standard practice across Australian peptide research. It is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.
Every batch of this blend sold across Australia is independently HPLC tested, with a Certificate of Analysis verifying both peptide components.
Yes - Australian researchers wanting to add GHK-Cu's copper-binding research profile to this combination can look at our three and four-peptide blends. (!) View our GLOW Blend or KLOW Blend.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
